Longeveron 관리
관리 기준 확인 0/4
Longeveron's CEO is Mohamed Wa'el Hashad, appointed in Feb 2023, has a tenure of 1.75 years. total yearly compensation is $1.66M, comprised of 25.9% salary and 74.1% bonuses, including company stock and options. directly owns 1.94% of the company’s shares, worth $564.87K. The average tenure of the management team and the board of directors is 1.3 years and 2.4 years respectively.
주요 정보
Mohamed Wa'el Hashad
최고 경영자
US$1.7m
총 보상
| CEO 급여 비율 | 25.9% |
| CEO 임기 | 1.8yrs |
| CEO 소유권 | 1.9% |
| 경영진 평균 재임 기간 | 1.3yrs |
| 이사회 평균 재임 기간 | 2.4yrs |
최근 관리 업데이트
Recent updates
Will Longeveron (NASDAQ:LGVN) Spend Its Cash Wisely?
Nov 17
Longeveron Inc.: A New Approach To Treat Alzheimer's
Oct 09Longeveron spikes after FDA’s Fast Track Designation for lead candidate
Aug 31Is Longeveron (NASDAQ:LGVN) In A Good Position To Invest In Growth?
Jul 15Longeveron rises ~20%, co to present Alzheimer's trial abstract at leading conference
Jul 07Longeveron: Small-Cap Biotech Targeting Large Alzheimer's Market
May 06CEO 보상 분석
| 날짜 | 총 보상 | 급여 | 회사 수익 |
|---|---|---|---|
| Jun 30 2024 | n/a | n/a | -US$28m |
| Mar 31 2024 | n/a | n/a | -US$22m |
| Dec 31 2023 | US$2m | US$431k | -US$22m |
보상 대 시장: Mohamed Wa'el's total compensation ($USD1.66M) is above average for companies of similar size in the US market ($USD655.65K).
보상과 수익: Insufficient data to compare Mohamed Wa'el's compensation with company performance.
CEO
Mohamed Wa'el Hashad (62 yo)
1.8yrs
테뉴어
US$1,662,854
보상
Mr. Mohamed Wa'el Ahmed Hashad, M.B.A. has been Chief Executive Officer at Longeveron Inc. since February 2023 and also has been its Director since June 09, 2023. Mr. Hashad has been Independent Director a...
리더십 팀
| 이름 | 위치 | 테뉴어 | 보상 | 소유권 |
|---|---|---|---|---|
| Co-Founder | 10.8yrs | US$87.13k | 8.29% $ 2.4m | |
| CEO & Director | 1.8yrs | US$1.66m | 1.94% $ 564.9k | |
| CFO & Treasurer | 1.3yrs | US$604.67k | 1.1% $ 321.4k | |
| International Executive Director | no data | US$554.06k | 1.11% $ 323.9k | |
| Senior Vice President of Strategic Collaborations & Scientific Affairs | 3.5yrs | 데이터 없음 | 데이터 없음 | |
| Chief Medical Officer | 1.3yrs | 데이터 없음 | 1.1% $ 320.4k | |
| Vice President of Manufacturing | no data | 데이터 없음 | 데이터 없음 | |
| VP of Research & Discovery | no data | 데이터 없음 | 데이터 없음 | |
| VP & Corporate Controller | less than a year | 데이터 없음 | 데이터 없음 | |
| VP & Corporate Controller | less than a year | 데이터 없음 | 데이터 없음 |
1.3yrs
평균 재임 기간
55.5yo
평균 연령
경험이 풍부한 관리: LGVN's management team is not considered experienced ( 1.3 years average tenure), which suggests a new team.
이사회 구성원
| 이름 | 위치 | 테뉴어 | 보상 | 소유권 |
|---|---|---|---|---|
| Co-Founder | 10.8yrs | US$87.13k | 8.29% $ 2.4m | |
| CEO & Director | 1.4yrs | US$1.66m | 1.94% $ 564.9k | |
| Independent Director | less than a year | 데이터 없음 | 데이터 없음 | |
| Independent Director | less than a year | 데이터 없음 | 데이터 없음 | |
| Member of Scientific Advisory Board | no data | 데이터 없음 | 데이터 없음 | |
| Independent Director | 1.4yrs | US$47.78k | 0.10% $ 30.2k | |
| Member of Scientific Advisory Board | no data | 데이터 없음 | 데이터 없음 | |
| Member of Scientific Advisory Board | no data | 데이터 없음 | 데이터 없음 | |
| Member of Scientific Advisory Board | no data | 데이터 없음 | 데이터 없음 | |
| Director | 9.2yrs | US$52.13k | 2.13% $ 619.6k | |
| Director | 4.7yrs | US$55.63k | 1.45% $ 423.3k | |
| Independent Director | 3.4yrs | US$62.63k | 0.0035% $ 1.0k |
2.4yrs
평균 재임 기간
61.5yo
평균 연령
경험이 풍부한 이사회: LGVN's board of directors are not considered experienced ( 2.4 years average tenure), which suggests a new board.